Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antibody-drug conjugates in triple negative breast cancer.
Tray N, Adams S, Esteva FJ. Tray N, et al. Among authors: esteva fj. Future Oncol. 2018 Oct;14(25):2651-2661. doi: 10.2217/fon-2018-0131. Epub 2018 Sep 3. Future Oncol. 2018. PMID: 30175620 Review.
Pertuzumab in the treatment of HER2+ breast cancer.
Jhaveri K, Esteva FJ. Jhaveri K, et al. Among authors: esteva fj. J Natl Compr Canc Netw. 2014 Apr;12(4):591-8. doi: 10.6004/jnccn.2014.0059. J Natl Compr Canc Netw. 2014. PMID: 24717573 Review.
HER family kinase domain mutations promote tumor progression and can predict response to treatment in human breast cancer.
Boulbes DR, Arold ST, Chauhan GB, Blachno KV, Deng N, Chang WC, Jin Q, Huang TH, Hsu JM, Brady SW, Bartholomeusz C, Ladbury JE, Stone S, Yu D, Hung MC, Esteva FJ. Boulbes DR, et al. Among authors: esteva fj. Mol Oncol. 2015 Mar;9(3):586-600. doi: 10.1016/j.molonc.2014.10.011. Epub 2014 Nov 11. Mol Oncol. 2015. PMID: 25435280 Free PMC article.
Circulating tumor cell analysis in metastatic triple-negative breast cancers.
Magbanua MJ, Carey LA, DeLuca A, Hwang J, Scott JH, Rimawi MF, Mayer EL, Marcom PK, Liu MC, Esteva FJ, Park JW, Rugo HS; Translational Breast Cancer Research Consortium. Magbanua MJ, et al. Among authors: esteva fj. Clin Cancer Res. 2015 Mar 1;21(5):1098-105. doi: 10.1158/1078-0432.CCR-14-1948. Epub 2014 Dec 18. Clin Cancer Res. 2015. PMID: 25524311
A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer.
Jhaveri K, Wang R, Teplinsky E, Chandarlapaty S, Solit D, Cadoo K, Speyer J, D'Andrea G, Adams S, Patil S, Haque S, O'Neill T, Friedman K, Esteva FJ, Hudis C, Modi S. Jhaveri K, et al. Among authors: esteva fj. Breast Cancer Res. 2017 Aug 2;19(1):89. doi: 10.1186/s13058-017-0879-5. Breast Cancer Res. 2017. PMID: 28764748 Free PMC article. Clinical Trial.
231 results